Donald L. Anglin v. Blue Shield of Virginia and Blue Cross of Virginia

693 F.2d 315, 1982 U.S. App. LEXIS 24154
CourtCourt of Appeals for the Fourth Circuit
DecidedNovember 10, 1982
Docket81-1246
StatusPublished
Cited by8 cases

This text of 693 F.2d 315 (Donald L. Anglin v. Blue Shield of Virginia and Blue Cross of Virginia) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fourth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Donald L. Anglin v. Blue Shield of Virginia and Blue Cross of Virginia, 693 F.2d 315, 1982 U.S. App. LEXIS 24154 (4th Cir. 1982).

Opinion

WIDENER, Circuit Judge:

The plaintiff in this action is an individual who sought to purchase a health insurance policy from the defendants for himself and a minor son. The plaintiff did not wish coverage for his wife who had other health insurance as a result of her employment. The defendants offer only a policy that would cover plaintiff, his wife, and son. Under defendant’s rule, plaintiff must enroll according to his marital status. 1 Plaintiff brought suit alleging that requiring him to purchase a policy to include his wife resulted from violations of Sections 1 and 2 of the Sherman Antitrust Act, 15 U.S.C. §§ 1, 2. The district court, 510 F.Supp. 75, granted defendant’s motion to dismiss made under Federal Rule of Civil Procedure 12(b)(6), and we affirm.

Defendants are non-stock Virginia corporations known commonly as the “Blues.” They are organized under Title 38.1 of the Virginia Code, styled “Insurance,” §§ 38.1-810 to 834, to provide hospital and medical and surgical services through the sale of prepaid subscriber contracts to individuals and groups. Blue Cross has member hospitals, while Blue Shield has member physicians providing services. Id. §§ 38.1-810, 811. While the entities are legally distinct, they offer joint coverage, and the administration for both programs is handled by Blue Cross. Id. § 38.1-812. The defendants assert that they are immune from the suit at bar under the McCarran-Ferguson Act, 15 U.S.C. §§ 1011-1013, which exempts State regulated aspects of “the business of insurance” from federal antitrust law. 2

We consider two principal issues in deciding whether the plaintiff’s complaint concerns the “business of insurance.” First, there is the issue of whether or not Blue Cross/Blue Shield may ever be considered to be carrying on the business of insurance. If that issue is answered affirmatively, then we must consider whether the particular relationship at hand between the plaintiff *317 and defendants concerns the business of insurance.

The question of whether various aspects of Blue Cross/Blue Shield operations come within the McCarran-Ferguson Act has been litigated many times. E.g., Group Health & Life Insurance Co. v. Royal Drug Co., 440 U.S. 205, 99 S.Ct. 1067, 59 L.Ed.2d 261 (1979); Virginia Academy of Clinical Psychologists v. Blue Shield, 624 F.2d 476 (4th Cir.1980), cert. denied, 450 U.S. 916, 101 S.Ct. 1360, 67 L.Ed.2d 342 (1981); Travelers Insurance Co. v. Blue Cross of Western Pennsylvania, 481 F.2d 80 (3d Cir.), cert. denied, 414 U.S. 1093, 94 S.Ct. 724, 38 L.Ed.2d 550 (1973). Until recently some decisions had almost assumed that under certain circumstances Blue Cross/Blue Shield could be characterized as carrying on the business of insurance. See Travelers Insurance Co., 481 F.2d at 83; Nankin Hospital v. Michigan Hospital Service, 361 F.Supp. 1199, 1211 (E.D.Mich.1973). The Supreme Court opinion in Royal Drug, however, altered the efficacy of that position, for it reasoned that the particular relationship being questioned had to be examined in each ease.

The alleged underlying antitrust violation in Royal Drug was Texas Blue Shield’s policy of limiting reimbursement to cost plus $2 for prescriptions filled by pharmacies which had not entered into a Pharmacy Agreement with Blue Shield. 440 U.S. at 209, 99

S.Ct. at 1072. Blue Shield argued that scrutiny of the policy was beyond the reach of federal antitrust statutes because the Pharmacy Agreements were part of the “business of insurance” within the meaning of McCarran-Ferguson. Id. at 210, 99 S.Ct. at 1072. The Supreme Court analyzed the history of McCarran-Ferguson and concluded that the exemption provided by the Act was narrow and that it did not apply to the contracts between Blue Shield and the pharmacies. Id. at 231-33, 99 S.Ct. at 1083-84 (applied in Virginia Academy of Clinical Psychologists, supra, to the payment of bills of clinical psychologists).

Relevant to the matter at hand is the Court’s discussion in Royal Drug of Congress’ reasoning behind the exemption of the business of insurance from antitrust laws. 3 The Court read the legislative history of the Act to indicate that Congress understood the business of insurance to consist of the underwriting and spreading of risk. 440 U.S. at 220-21, 99 S.Ct. at 1077-78. It contrasted such risk taking with the operation of organizations providing prepaid health care services to their members. The Court concluded that at the time Congress passed McCarran-Ferguson such organizations were not considered to be insurance companies and therefore they were not engaged in the “business of insurance” under the Act. Id. at 225-27, 99 S.Ct. at 1080-81. 4 The case cited approvingly a *318 D.C. Circuit case which had discussed the differences between risk taking insurers and prepaid health care plans.

Although Group Health’s [the prepaid health plan] activities may be considered in one aspect as creating security against loss from illness and accident, more truly they constitute the quantity purchase of well-rounded, continuous medical service by its members. Group Health is in fact and in function a consumer cooperative. The functions of such an organization are not identical with those of insurance or indemnity companies. The latter are concerned primarily, if not exclusively, with risk.... On the other hand, the cooperative is concerned principally with getting service rendered to its members and doing so at lower prices made possible by quantity purchasing and economies in operation.

440 U.S. at 228, 99 S.Ct. at 1081, quoting Jordan v. Group Health Ass’n, 107 F.2d 239, 247 (D.C.Cir.1939) (emphasis appeared in Royal Drug quotation).

Furthermore, the Court in Royal Drug noted that some courts have held Blue Cross/Blue Shield organizations not to be insurance companies 5 and, in some circumstances, Blue Cross/Blue Shield has argued that it is not an insurance company. 6 Nevertheless, the Court did not conclude that Blue Shield is never properly considered an insurer and, to the contrary, in a statement applicable to the instant case, the Court said:

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
693 F.2d 315, 1982 U.S. App. LEXIS 24154, Counsel Stack Legal Research, https://law.counselstack.com/opinion/donald-l-anglin-v-blue-shield-of-virginia-and-blue-cross-of-virginia-ca4-1982.